Stryker (NYSE: SYK) ended the last trading session at $49.16. So far the stock has hit a 52-week low of $30.82 and 52-week high of $49.78. Stryker stock has been showing support around 48.62 and resistance in the 49.60 range. Technical indicators for the stock are Bullish and S&P gives SYK a positive 4 STAR...(Click the story link or go to http://www.marketintelligencecenter.com for the full story)
Analysts were expecting Covidien plc (COV) [Chart - News - Analysis] to report earnings of $0.70 for last quarter, but COV beat expectations with actual earnings of $0.72---2 cents above the consensus estimate.
If you compare last quarter's earnings to the $0.73 the company made per share during the same quarter a year ago, you can see that COV’s earnings are down this year.
{loadposition link_newslink1}
{loadposition livevideopromo}
{loadposition homeaccordion2}
{loadposition contentad}
Also, if you compare COV's 10.77% projected earnings-per-share (EPS) growth rate for the next five years with the projected EPS growth rate of 13.23% for the Medical Instruments & Supplies industry as a whole during that same time frame, you can see that analysts expect COV to underperform the industry in the future---which is a bad sign for the stock.
Drilling down a little deeper into the Medical Instruments & Supplies industry, you can see how analysts believe COV will stack up against some of the other stocks in the industry, like CareFusion Corporation (CFN) [Chart - News - Analysis] and Stryker Corp. (SYK) [Chart - News - Analysis], in the future. Analysts believe CFN's earnings are going to grow at a rate of 14.50% while SYK's earnings are going to grow at a rate of 12.10%.
Earnings season can be a volatile time in the stock market. Check out these videos and articles to be better prepared to take advantage of the large price moves that tend to accompany earnings announcements.
Stryker Corp. (SYK) is on a takeover spree having made three acquisitions recently. The company acquired OtisMed Corp., Mutoh Co. Ltd. and certain of its affiliates, and Synergetics USA, Inc. (SURG). Financial terms of these transactions include $67 million in upfront payment as well as potential future milestone and royalty payments of up to $36 million. These [...]
Zimmer Holdings, Inc. (ZMH) recently decided to raise $1 billion by selling its senior unsecured notes in an underwritten public offering in two separate transactions. The transactions involve selling $500.0 million of 4.625% notes due 2019 and $500.0 million of 5.75% notes due 2039. The public offering is expected to close on Nov 17, 2009.
Zimmer [...]
Zimmer Holdings, Inc. (ZMH) recently decided to raise $1 billion by selling its senior unsecured notes in an underwritten public offering in two separate transactions. The transactions involve selling $500.0 million of 4.625% notes due 2019 and $500.0 million of 5.75% notes due 2039. The public offering is expected to close on Nov 17, 2009.
Zimmer has already filed an automatic shelf registration statement on Form S-3 with the Securities and Exchange Commission for the public offer. Citigroup Global Markets Inc., a division of Citigroup, Inc. (C); Banc of America Securities LLC, a division of Bank of America Corp. (BAC); and J.P. Morgan Securities Inc., a division of JPMorgan Chase & Co. (JPM) are the active joint book-running managers of the offering. The offer will be made to the public through the prospectus.
The 2019 notes yield 118 basis points above the Treasury benchmark and the 2039 notes yield 135 basis points above the Treasury benchmark. Zimmer will use the net proceeds of the offering to repay its outstanding credit balance under its credit facility and for general corporate purposes like the company’s stock repurchase program. Zimmer already had cash and cash equivalents of roughly $440 million at the end of the third quarter of 2009.
All News |
Breaking News |
Featured Stories